Article
Nomogram for predicting PCa recurrence is validated
New York-A computer model nomogram that uses three preoperative prostate cancer variables to predict probabilities for cancer recurrence within 5 years has been successfully validated. The nomogram will not only aid physicians in making treatment decisions, but it could also help improve patients' ability to make decisions about their treatment, according to researchers from Memorial Sloan-Kettering Cancer Center in New York.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Related Videos
Andrea Pezzella, MD, URPS, FACOG, discusses Neuspera’s SNM device
Ashley Winter, MD, calls for label update on low-dose vaginal estrogen
The ADVANCED-2 trial, TARA-002
Unmet needs in high risk NMIBC
Joseph Song, MD, on the emergence of new suction-based devices for stone disease
How eating disorders affect bladder and pelvic floor health
Fitting Oral ADT Options Into the Prostate Cancer Treatment Plans
The Current Landscape of ADT in Prostate Cancer
Daniel D. Joyce, MD, MS, discusses the economics of trimodal therapy in MIBC
Sarah Razavi, MD, outlines strategies for mitigate surgeon discomfort during URS
Related Content
